{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:35:36Z","timestamp":1788345336074,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurom.2024.07.007","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T22:50:02Z","timestamp":1725231002000},"page":"1054-1058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Real-World Prescription Data for Intrathecal Drug Delivery: A Retrospective Analysis in 32,784 Patients"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0221-9255","authenticated-orcid":false,"given":"David","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Di Capua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeet","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurom.2024.07.007_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11916-014-0474-8","article-title":"History and present state of targeted intrathecal drug delivery","volume":"19","author":"Rizvi","year":"2015","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.neurom.2024.07.007_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3171\/jns.1982.56.2.0241","article-title":"Intrathecal and intraventricular morphine for pain in cancer patients: initial study","volume":"56","author":"Leavens","year":"1982","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neurom.2024.07.007_bib3","first-page":"223","article-title":"Use of intrathecal and epidural morphine for pain relief in patients with malignant diseases: a preliminary report","volume":"13","author":"Rico","year":"1982","journal-title":"J Med"},{"key":"10.1016\/j.neurom.2024.07.007_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.21037\/atm-20-3814","article-title":"Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications","volume":"9","author":"Capozza","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.neurom.2024.07.007_bib5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2147\/JPR.S344409","article-title":"Intrathecal drug delivery systems survey: trends in utilization in pain practice","volume":"15","author":"Abd-Sayed","year":"2022","journal-title":"J Pain Res"},{"key":"10.1016\/j.neurom.2024.07.007_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/ner.12618","article-title":"recommendations on intrathecal drug infusion systems best practices and guidelines","volume":"20","year":"2017","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2024.07.007_bib7","first-page":"615","article-title":"Current perspectives on intrathecal drug delivery","volume":"7","author":"Bottros","year":"2014","journal-title":"J Pain Res"},{"key":"10.1016\/j.neurom.2024.07.007_bib8","unstructured":"US Food and Drug Administration. Infumorph 200 Infumorph 500 (preservative-free morphine sulfate sterile solution). Accessed August 22, 2024. https:\/\/www.fda.gov\/drugsatfda"},{"key":"10.1016\/j.neurom.2024.07.007_bib9","unstructured":"US Food and Drug Administration. Prialt (ziconotide intrathecal infusion). Accessed August 22, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/021060s003lbl.pdf"},{"key":"10.1016\/j.neurom.2024.07.007_bib10","unstructured":"US Food and Drug Administration. Lioresal intrathecal (baclofen injection). Accessed August 22, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020075s037lbl.pdf"},{"key":"10.1016\/j.neurom.2024.07.007_bib11","unstructured":"US Food and Drug Administration. Gablofen (baclofen injection). Accessed August 22, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/022462s000lbl.pdf"},{"key":"10.1016\/j.neurom.2024.07.007_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00000542-200507000-00026","article-title":"From the FDA: what\u2019s in a label? A guide for the anesthesia practitioner","volume":"103","author":"Chang","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neurom.2024.07.007_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1748-720X.2009.00408.x","article-title":"Off-label prescribing: a call for heightened professional and government oversight","volume":"37","author":"Dresser","year":"2009","journal-title":"J Law Med Ethics"},{"key":"10.1016\/j.neurom.2024.07.007_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/ner.12961","article-title":"Physician guidance on the use of off-labeled drugs in intrathecal drug delivery systems for chronic pain","volume":"22","author":"Deer","year":"2019","journal-title":"Neuromodulation"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715924006615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715924006615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:24:16Z","timestamp":1760538256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715924006615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1094715924006615"],"URL":"https:\/\/doi.org\/10.1016\/j.neurom.2024.07.007","relation":{},"ISSN":["1094-7159"],"issn-type":[{"value":"1094-7159","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Prescription Data for Intrathecal Drug Delivery: A Retrospective Analysis in 32,784 Patients","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurom.2024.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Neuromodulation Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}